Peripheral neuropathy associated with fluoroquinolones

Annals of Pharmacotherapy

Volumn 35, Issue 12, 2001, Pages 1540-1547

  Cohen, J S ^a  

^a NONE   (United States)

Author keywords

Adverse events; Ciprofloxacin; Fluoroquinolones; Levofloxacin; Lomefloxacin; Ofloxacin; Trovafloxacin

Indexed keywords

BENZODIAZEPINE; CIPROFLOXACIN; CLONAZEPAM; DIAZEPAM; LEVOFLOXACIN; LOMEFLOXACIN; LORAZEPAM; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TROVAFLOXACIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG INDICATION; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERNET; MALE; MEDICAL INFORMATION; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

EID: 0035659541     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Z429     Document Type: Article

References (38)

1. Fluoroquinolone antimicrobial agents
2. Toxicity of quinolones
3. Neurotoxicity of antibacterial therapy
4. Central nervous system toxicity of quinolones: Human and animal findings
5. Potential neurologic toxicity related to ciprofloxacin
6. Fluoroquinolone toxicities. An update
7. Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model
8. Ciprofloxacin-induced acute psychosis
9. Fluoroquinolone toxicity profiles: A review focusing on newer agents
10. Seizures associated with ofloxacin therapy
11. Levofloxacin, a second-generation fluoroquinolone
12. Peripheral neuropathy associated with fluoroquinolones
13. Trovafloxacin-induced weakness due to a demyelinating polyneuropathy
14. Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group
15. Neurologic adverse effects during concomitant treatment with ciprofloxacin, NSAIDs, and chloroquine: Possible drug interaction
16. Clinical experience with pefloxacin in patients with urinary tract infections
17. Peripheral sensory disturbances related to treatment with fluoroquinolones
18. A run on antibiotics
19. Requirements on content and format of labeling for human prescription drugs and biologics: Proposed rule
20. A method for estimating the probability of adverse drug reactions
21. Erythromelalgia: New theories and new therapies
22. Fluoroquinolone toxicity profiles: A review tocusing on newer agents
23. Effects of quinolones on the central nervous system
24. Adverse effects
25. Tolerability of fluoroquinolone antibiotics. Past, present and future
26. Retrospective analysis of the safety profile of oral and intravenous ciprofloxacin in a geriatric population
27. Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone
28. Fluoroquinolone toxicities. An update
29. Potential interactions of the extended-spectrum fluoroquinolones with the CNS
30. Fluoroquinolone antibiotics block neuromuscular transmission
31. The top 200 drugs of 2000
32. The safety profile of the fluoroquinolones
33. Prevention and management of drug-induced peripheral neuropathy
34. Pharmacokinetic interactions related to the chemical structures of fluoroquinolones
35. The fluoroquinolones
36. Quinolones: A practical review of clinical uses, dosing considerations, and drug interactions